Lexicon Pharmaceuticals (LXRX) director converts 89,312 RSUs into 213,771-share stake
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
LEXICON PHARMACEUTICALS director Sam L. Barker exercised restricted stock units into common shares. On 2026-06-03, 89,312 restricted stock units converted into 89,312 shares of common stock at a stated price of $0.00 per share, reflecting equity compensation rather than an open‑market trade.
Following this conversion, Barker directly owns 213,771 shares of common stock. The footnotes explain that each restricted stock unit represented a contingent right to receive one share of common stock, and that the award vested in full on the first anniversary of its grant date.
Positive
- None.
Negative
- None.
Insider Trade Summary
89,312 shares exercised/converted
Mixed
2 txns
Insider
BARKER SAM L
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 89,312 | $0.00 | -- |
| Exercise | Common Stock | 89,312 | $0.00 | -- |
Holdings After Transaction:
Restricted Stock Units — 0 shares (Direct, null);
Common Stock — 213,771 shares (Direct, null)
Footnotes (1)
- Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. Each restricted stock unit represents a contingent right to receive one share of common stock.
Key Figures
RSUs exercised: 89,312 units
Common shares received: 89,312 shares
Post-transaction holdings: 213,771 shares
+1 more
4 metrics
RSUs exercised
89,312 units
Restricted stock units converted to common stock on 2026-06-03
Common shares received
89,312 shares
Shares of common stock issued upon RSU conversion
Post-transaction holdings
213,771 shares
Common stock directly owned after RSU exercise
Exercise price per share
$0.00/share
Stated price for RSU conversion into common stock
Key Terms
Restricted Stock Units, derivative security, contingent right
3 terms
Restricted Stock Units financial
"The footnotes explain that each restricted stock unit represented a contingent right to receive one share of common stock"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
derivative security financial
"transaction_code_description: Exercise or conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
contingent right financial
"Each restricted stock unit represents a contingent right to receive one share of common stock"
FAQ
What insider transaction did Sam L. Barker report for LEXICON PHARMACEUTICALS (LXRX)?
Sam L. Barker reported exercising 89,312 restricted stock units into common stock. The units converted to 89,312 shares at a stated price of $0.00 per share, reflecting an equity compensation event rather than an open‑market purchase or sale.
What security did Sam L. Barker convert in the Lexicon Pharmaceuticals (LXRX) Form 4?
He converted restricted stock units into common stock. Specifically, 89,312 restricted stock units, each representing a contingent right to receive one share, were exercised and settled into 89,312 shares of Lexicon Pharmaceuticals common stock.
Was Sam L. Barker’s Lexicon Pharmaceuticals (LXRX) Form 4 transaction a market buy or sell?
No, it was not a market buy or sell. The Form 4 shows a derivative exercise, where 89,312 restricted stock units converted into common stock at $0.00 per share as part of equity compensation, with no reported open‑market purchase or sale.
How did the restricted stock units in Lexicon Pharmaceuticals (LXRX) vest for Sam L. Barker?
The restricted stock units vested 100% on the first anniversary of their grant date. Each unit represented a contingent right to receive one share of Lexicon Pharmaceuticals common stock, and the vested units were then converted into 89,312 common shares.